These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 33236938)

  • 21. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
    Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
    Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation of mesoporous silica/hydroxyapatite loaded quercetin nanoparticles and research on its antibacterial properties.
    Yi X; Bao F; Fu S; Yang Y; Xu Y
    Med Eng Phys; 2024 Apr; 126():104160. PubMed ID: 38621842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.
    Lu J; Liong M; Li Z; Zink JI; Tamanoi F
    Small; 2010 Aug; 6(16):1794-805. PubMed ID: 20623530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Janus silver mesoporous silica nanobullets with synergistic antibacterial functions.
    Chang ZM; Wang Z; Lu MM; Shao D; Yue J; Yang D; Li MQ; Dong WF
    Colloids Surf B Biointerfaces; 2017 Sep; 157():199-206. PubMed ID: 28595136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation, Characterization, and Evaluation of the Anticancer Effect of Mesoporous Silica Nanoparticles Containing Rutin and Curcumin.
    Dizaj SM; Kouhsoltani M; Pourreza K; Sharifi S; Abdolahinia ED
    Pharm Nanotechnol; 2024; 12(3):269-275. PubMed ID: 37594097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liquid CO
    Raza A; Sime FB; Cabot PJ; Roberts JA; Falconer JR; Kumeria T; Popat A
    ACS Biomater Sci Eng; 2021 May; 7(5):1836-1853. PubMed ID: 33438994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesoporous silica nanoparticles as carrier to overcome bacterial drug resistant barriers.
    Zhuang J; Yu Y; Lu R
    Int J Pharm; 2023 Jan; 631():122529. PubMed ID: 36563796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomedical application of mesoporous silica nanoparticles as delivery systems: a biological safety perspective.
    Hosseinpour S; Walsh LJ; Xu C
    J Mater Chem B; 2020 Nov; 8(43):9863-9876. PubMed ID: 33047764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staggering the administration of polymyxin B and meropenem in time-kill against carbapenem-resistant Enterobacteriaceae exhibiting a wide range of meropenem MICs.
    Kulengowski B; Clark JA; Burgess DS
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):261-264. PubMed ID: 30344066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino-decorated mesoporous silica nanoparticles for controlled sofosbuvir delivery.
    Mehmood Y; Khan IU; Shahzad Y; Khan RU; Khalid SH; Yousaf AM; Hussain T; Asghar S; Khalid I; Asif M; Shah SU
    Eur J Pharm Sci; 2020 Feb; 143():105184. PubMed ID: 31846695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. pH-Responsive Mesoporous Silica Nanoparticles Loaded with Naringin for Targeted Osteoclast Inhibition and Bone Regeneration.
    Gong S; Lang S; Wang Y; Li X; Tian A; Ma J; Ma X
    Int J Nanomedicine; 2024; 19():6337-6358. PubMed ID: 38946884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-Delivery of Epirubicin and siRNA Using Functionalized Mesoporous Silica Nanoparticles Enhances In vitro and In vivo Drug Efficacy.
    Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Abnous K; Malaekeh-Nikouei B
    Curr Drug Deliv; 2016; 13(7):1176-1182. PubMed ID: 26718488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facile, one-pot synthesis, and antibacterial activity of mesoporous silica nanoparticles decorated with well-dispersed silver nanoparticles.
    Tian Y; Qi J; Zhang W; Cai Q; Jiang X
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):12038-45. PubMed ID: 25050635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial and biodegradable tissue nano-adhesives for rapid wound closure.
    Lu MM; Bai J; Shao D; Qiu J; Li M; Zheng X; Xiao Y; Wang Z; Chang ZM; Chen L; Dong WF; Tang CB
    Int J Nanomedicine; 2018; 13():5849-5863. PubMed ID: 30310284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
    Cui Y; Dong H; Cai X; Wang D; Li Y
    ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs.
    Jia L; Shen J; Li Z; Zhang D; Zhang Q; Duan C; Liu G; Zheng D; Liu Y; Tian X
    Int J Pharm; 2012 Dec; 439(1-2):81-91. PubMed ID: 23078857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation and Controllability of Mesoporous Silica Nanoparticles.
    Yamamoto E; Kuroda K
    Enzymes; 2018; 44():1-10. PubMed ID: 30360809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles.
    He Q; Zhang J; Chen F; Guo L; Zhu Z; Shi J
    Biomaterials; 2010 Oct; 31(30):7785-96. PubMed ID: 20674009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.